ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för erteberel. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

18 träffar

Bibliografisk träff 2024-03-21

Activation of ERβ hijacks the splicing machinery to trigger R-loop formation in triple-negative breast cancer.

Wang D, Tang M, Zhang P, Yang K, Huang L, Wu M, Shen Q, Yue J, Wang W, Gong Y, Warner M, Dai L, He H, Yang Z, Gustafsson JA, Zhou S.

Proc Natl Acad Sci U S A · research-article; journal article; research support, n.i.h., extramural · DOI 10.1073/pnas.2306814121

Bibliografisk träff 2023-09-14

Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer.

Venkata PP, Jayamohan S, He Y, Alejo S, Johnson JD, Palacios BE, Pratap UP, Chen Y, Liu Z, Zou Y, Lai Z, Suzuki T, Viswanadhapalli S, Weintraub ST, Palakurthi S, Valente PT, Tekmal RR, Kost ER, Vadlamudi RK, Sareddy GR.

Cancer Lett · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.canlet.2023.216383

Bibliografisk träff 2022-06-28

Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist.

He Y, Alejo S, Venkata PP, Johnson JD, Loeffel I, Pratap UP, Zou Y, Lai Z, Tekmal RR, Kost ER, Sareddy GR.

Int J Mol Sci · research-article; journal article · DOI 10.3390/ijms23137159

Bibliografisk träff 2022-05-28

Ahi1 regulates serotonin production by the GR/ERβ/TPH2 pathway involving sexual differences in depressive behaviors.

Wang B, Shi H, Ren L, Miao Z, Wan B, Yang H, Fan X, Gustafsson JA, Sun M, Xu X.

Cell Commun Signal · video-audio media; research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/s12964-022-00894-4

Bibliografisk träff 2022-04-25

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer.

Datta J, Willingham N, Manouchehri JM, Schnell P, Sheth M, David JJ, Kassem M, Wilson TA, Radomska HS, Coss CC, Bennett CE, Ganju RK, Sardesai SD, Lustberg M, Ramaswamy B, Stover DG, Cherian MA.

Front Oncol · research-article; journal article · DOI 10.3389/fonc.2022.857590

Bibliografisk träff 2022-03-06

Different Susceptibilities of Human Melanoma Cell Lines to G2/M Blockage and Cell Death Activation in Response to the Estrogen Receptor β agonist LY500307.

Pontecorvi G, Bellenghi M, Tait S, Tirelli V, Matarrese P, Mattia G, Carè A, Puglisi R.

J Cancer · research-article; journal article · DOI 10.7150/jca.65425

Bibliografisk träff 2021-07-22

Mitochondrial estrogen receptors alter mitochondrial priming and response to endocrine therapy in breast cancer cells.

Karakas B, Aka Y, Giray A, Temel SG, Acikbas U, Basaga H, Gul O, Kutuk O.

Cell Death Discov · research-article; journal article · DOI 10.1038/s41420-021-00573-2

Bibliografisk träff 2021-02-01

Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.

Sareddy GR, Pratap UP, Venkata PP, Zhou M, Alejo S, Viswanadhapalli S, Tekmal RR, Brenner AJ, Vadlamudi RK.

Stem Cells · research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1002/stem.3337

Bibliografisk träff 2021-01-01

Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma.

Pratap UP, Sareddy GR, Liu Z, Venkata PP, Liu J, Tang W, Altwegg KA, Ebrahimi B, Li X, Tekmal RR, Viswanadhapalli S, McHardy S, Brenner AJ, Vadlamudi RK.

Neurooncol Adv · research-article; journal article · DOI 10.1093/noajnl/vdab099

Bibliografisk träff 2020-08-12

Pharmacological Activation of Estrogen Receptor Beta Overcomes Tumor Resistance to Immune Checkpoint Blockade Therapy.

Huang S, Zhou N, Zhao L, Gimple RC, Ahn YH, Zhang P, Wang W, Shao B, Yang J, Zhang Q, Zhao S, Jiang X, Chen Z, Zeng Y, Hu H, Gustafsson JÅ, Zhou S.

iScience · research-article; journal article · DOI 10.1016/j.isci.2020.101458

Bibliografisk träff 2018-03-28

Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis.

Zhao L, Huang S, Mei S, Yang Z, Xu L, Zhou N, Yang Q, Shen Q, Wang W, Le X, Lau WB, Lau B, Wang X, Yi T, Zhao X, Wei Y, Warner M, Gustafsson JÅ, Zhou S.

Proc Natl Acad Sci U S A · research support, non-u.s. gov't; research-article; journal article · DOI 10.1073/pnas.1803291115

Bibliografisk träff 2017-10-11

ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer.

Reese JM, Bruinsma ES, Monroe DG, Negron V, Suman VJ, Ingle JN, Goetz MP, Hawse JR.

Oncotarget · research-article; journal article · DOI 10.18632/oncotarget.21787

Bibliografisk träff 2016-04-29

Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma.

Sareddy GR, Li X, Liu J, Viswanadhapalli S, Garcia L, Gruslova A, Cavazos D, Garcia M, Strom AM, Gustafsson JA, Tekmal RR, Brenner A, Vadlamudi RK.

Sci Rep · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1038/srep24185

Bibliografisk träff 2015-06-08

Population pharmacokinetic/pharmacodynamic assessment of pharmacological effect of a selective estrogen receptor β agonist on total testosterone in healthy men.

Hu L, Jin Y, Li YG, Borel A.

Clin Pharmacol Drug Dev · journal article · DOI 10.1002/cpdd.184

Bibliografisk träff 2014-11-04

Estrogen receptor beta agonist LY500307 fails to improve symptoms in men with enlarged prostate secondary to benign prostatic hypertrophy.

Roehrborn CG, Spann ME, Myers SL, Serviss CR, Hu L, Jin Y.

Prostate Cancer Prostatic Dis · multicenter study; randomized controlled trial; journal article · DOI 10.1038/pcan.2014.43

Bibliografisk träff 2013-10-01

Fertility and developmental toxicity assessment in rats and rabbits with LY500307, a selective estrogen receptor beta (ERβ) agonist.

Hilbish KG, Breslin WJ, Johnson JT, Sloter ED.

Birth Defects Res B Dev Reprod Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1002/bdrb.21083

Bibliografisk träff 2007-07-13

Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 4: functionalization of the benzopyran A-ring.

Norman BH, Richardson TI, Dodge JA, Pfeifer LA, Durst GL, Wang Y, Durbin JD, Krishnan V, Dinn SR, Liu S, Reilly JE, Ryter KT.

Bioorg Med Chem Lett · journal article · DOI 10.1016/j.bmcl.2007.07.009

Bibliografisk träff 2006-10-01

Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia.

Norman BH, Dodge JA, Richardson TI, Borromeo PS, Lugar CW, Jones SA, Chen K, Wang Y, Durst GL, Barr RJ, Montrose-Rafizadeh C, Osborne HE, Amos RM, Guo S, Boodhoo A, Krishnan V.

J Med Chem · journal article · DOI 10.1021/jm060491j